pmid,title,journal,year,drug,disease
40810715,Cardiovascular Disease in Patients With Chronic Myeloid Leukemia: JACC: CardioOncology State-of-the-Art Review.,JACC. CardioOncology,2025,Dasatinib,Coronary Artery Disease
40745453,Telomere Dynamics in Cardiovascular Aging: From Molecular Mechanisms to Precision Medicine.,Cardiology in review,2025,Dasatinib,Coronary Artery Disease
35343478,[Cardiovascular management of patients with chronic myeloid leukemia treated with BCR-ABL tyrosine kinase inhibitors: it is time for a shared management].,Giornale italiano di cardiologia (2006),2022,Dasatinib,Coronary Artery Disease
32348984,Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience.,Oncology,2020,Dasatinib,Coronary Artery Disease
28378056,Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.,International journal of hematology,2017,Dasatinib,Coronary Artery Disease
28287043,Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors.,Journal of medical economics,2017,Dasatinib,Coronary Artery Disease
26373533,Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis.,Leukemia & lymphoma,2016,Dasatinib,Coronary Artery Disease
24794907,Dasatinib.,"Profiles of drug substances, excipients, and related methodology",2014,Dasatinib,Coronary Artery Disease
20399520,Cardiac side-effects of cancer chemotherapy.,International journal of cardiology,2010,Dasatinib,Coronary Artery Disease
